Tasas de letalidad por SARS-CoV-2 según Comunidades Autónomas durante la segunda onda epidémica en España

  1. A. Ruiz-García 1
  2. F. Vitelli-Storelli 2
  3. A. Serrano-Cumplido 3
  4. A. Segura-Fragoso 4
  5. A. Calderón-Montero 5
  6. R.M. Mico-Pérez 6
  7. A. Barquilla-García 7
  8. Á. Morán-Bayón 8
  9. M. Linares 9
  10. V. Olmo-Quintana 10
  11. V. Martín-Sánchez 11
  1. 1 Centro de Salud Universitario Pinto, Madrid, España
  2. 2 Universidad de León, León, España
  3. 3 Medicina Familiar y Comunitaria, Getxo, Bizkaia, España
  4. 4 Universidad Castilla La Mancha
  5. 5 Consorcio de Investigación Biomédica en Epidemiología y Salud Pública (CIBERESP), Madrid, España
  6. 6 Centro de Salud Fontanars dels Alforins, Agència Valenciana de Salut, Valencia, España
  7. 7 Centro de Salud de Trujillo, Servicio Extremeño de Salud, Cáceres, España
  8. 8 Centro de Salud de Alamedilla, Servicio de Salud de Castilla y León, Salamanca, España
  9. 9 SEMERGEN Grupo de Trabajo de Enfermedades Infecciosas, Medicina Tropical y Viajeros
  10. 10 Gerencia Servicio de Farmacia Atención Primaria de Salud, Hospital Dr. Negrín Gran Canaria Las Palmas
  11. 11 Universidad de León,Consorcio de Investigación Biomédica en Epidemiología y Salud Pública (CIBERESP), Madrid, España
Erakutsi afiliazioak +
Aldizkaria:
Semergen: revista española de medicina de familia

ISSN: 1138-3593

Argitalpen urtea: 2022

Zenbakia: 4

Orrialdeak: 252-262

Mota: Artikulua

DOI: 10.1016/J.SEMERG.2022.02.004 DIALNET GOOGLE SCHOLAR

Beste argitalpen batzuk: Semergen: revista española de medicina de familia

Laburpena

Introduction In Spain, health systems are transferred to the Autonomous Communities (AC), constituting 19 health systems with differentiated management and resources. During the first epidemic wave of COVID-19, differences were observed in reporting systems and in case-fatality rates (FR) between the AC. The objective of this study was to analyze the FR according to AC. during the 2 nd epidemic wave (from July 20 to December 25, 2020), and its relationship with the prevalence of infection. Material and methods A descriptive observational study was carried out, extracting the information available on the number of deaths from COVID-19 registered in the Ministry of Health, the Health Councils and the Public Health Departments of the AC, and according to the excess mortality reported by the System Monitoring of Daily Mortality (MoMo). The prevalence of infection was estimated from the differences between the second and fourth rounds of the ENE-COVID study and their 95% confidence intervals. The global FR (deaths per thousand infected) were calculated according to sex, age groups (< 65 and ≥ 65 years) and AC. The age-Standardized Fatality Rates (SFR) of the AC were calculated using the FR of Spain for each age group. These estimates were made with officially declared deaths (FRo) and excess deaths estimated by MoMo (FRMo). The correlations between the prevalences of infection and the FRo and FRMo were estimated, weighting by population. Results For the whole of Spain, the FRo during the second epidemic wave was 7.6%, oscillating between 3.8% in the Balearic Islands and 16.4% in Asturias, and the TLMo was 10.1%, oscillating between 4.8% from Madrid and 21.7% in Asturias. Significant differences were observed between the FRo and the FRMo in the Canary Islands, Castilla la Mancha, Extremadura, the Valencian Community, Andalusia and the Autonomous Cities of Ceuta and Melilla. The FRo was significantly higher in men (8.2%) than in women (7.1%). The FRo and FRMo were significantly higher in the age group ≥ 65 years (55.4% and 72.2% respectively) than in the group <65 years (0.5% and 1.4% respectively). The Basque Country, Aragon, Andalusia and Castilla la Mancha presented SFR significantly higher than the global FR of Spain. The correlations between the prevalence of infection and the FRo were inverse. Conclusions The case-fatality from COVID-19 during the second epidemic wave in Spain improved compared to the first wave. The case-fatality rates were higher in men and the elderly people, and varied significantly between AC. It is necessary to delve into the analysis of the causes of these differences.

Erreferentzia bibliografikoak

  • V. Martín-Sánchez, A. Barquilla-García, F. Vitelli-Stotelli, A. Segura-Fragoso, A. Ruiz-García, A. Serrano-Cumplido, et al. Análisis de las tasas de letalidad de la infección por SARS-CoV-2 en las comunidades autónomas de España Semergen., 46 (2020), pp. 12-19, 10.1016/j.semerg.2020.06.013 ArticleDownload PDFView Record in ScopusGoogle Scholar
  • L.E. Wong, J.E. Hawkins, S. Langness, K.L. Murrell, P. Iris, A. Sammann Where Are All the Patients? Addressing Covid-19 Fear to Encourage Sick Patients to Seek Emergency Care NEJM Catalyst. (2020), 10.1056/CAT.20.0193 View PDFGoogle Scholar
  • K.P. Hartnett, A. Kite-Powell, J. DeVies, M.A. Coletta, T.K. Boehmer, J. Adjemian, et al. Impact of the COVID-19 Pandemic on Emergency Department Visits — United States, January 1, 2019–May 30, 2020 MMWR Morb Mortal Wkly Rep., 69 (2020), pp. 699-704 Disponible en: https://www.cdc.gov/mmwr/volumes/69/wr/pdfs/mm6923e1-H.pdf. View PDFCrossRefGoogle Scholar
  • Pastor-Barriuso R, Pérez-Gómez B, Hernán MA, Pérez-Olmeda M, Yotti R, Oteo-Iglesias J, et al., ENE-COVID Study Group. Infection fatality risk for SARS-CoV-2 in community dwelling population of Spain: a nationwide seroepidemiological study. BMJ. 2020;371:m4509, https://doi.org/10.1136/bmj.m4509 Google Scholar
  • G. Giancreco Case fatality rate analysis of Italian COVID-19 outbreak J Med Virol., 92 (2020), pp. 919-923, 10.1002/jmv.25894 View PDFGoogle Scholar
  • R. Pastor-Barriuso, B. Pérez-Gómez, M.A. Hernán, M. Pérez-Olmeda, R. Yotti, J. Oteo-Iglesias, et al. Infection fatality risk for SARS-CoV-2: in a nationwide seroepidemiological study in the non-institutionalized population of Spain MedRxiv. (2020) [Consultado 30 marzo de 2021]. 10.1101/2020.08.06.20169722 Google Scholar
  • M. O’Driscoll, G. Ribeiro Dos Santos, L. Wang, D.A.T. Cummings, A.S. Azman, J. Paireau, et al. Age-specific mortality and immunity patterns of SARS-CoV-2 Nature., 590 (2021), pp. 140-145, 10.1038/s41586-020-2918-0 View PDFView Record in ScopusGoogle Scholar
  • L. Haynes Aging of the Immune System: Research Challenges to Enhance the Health Span of Older Adults Front Aging., 1 (2020), p. 602108, 10.3389/fragi.2020.602108 View PDFGoogle Scholar
  • H. Peckham, N.M. de Gruijter, C. Raine, A. Radziszewska, C. Ciurtin, L.R. Wedderburn, et al. Male sex identified by global COVID-19 meta-analysis as a risk factor for death and ITU admission Nat Commun., 11 (2020), 10.1038/s41467-020-19741-6 6317 (1-10). View PDFGoogle Scholar
  • S. Nourazari, S.R. Davis, R. Granovsky, R. Austin, D.J. Straff, J.W. Joseph, et al. Decreased hospital admissions through emergency departments during the COVID-19 pandemic Am J Emerg Med., 42 (2021), pp. 203-210, 10.1016/j.ajem.2020.11.029 ArticleDownload PDFView Record in ScopusGoogle Scholar
  • B. Frederiksen, U. Ranji, A. Salganicoff, M. Long Women's Experiences with Health Care During the COVID-19 Pandemic: Findings from the KFF Women's Health Survey Kaiser Family Foundation (KFF). (2021) [Consultado 30 marzo de 2021]. Disponible en: https://www.kff.org/womens-health-policy/issue-brief/womens-experiences-with-health-care-during-the-covid-19-pandemic-findings-from-the-kff-womens-health-survey/. Google Scholar
  • R. Ramón-Dangla, M.L. Rico-Gómez, R. Issa-Khozouz Mortalidad por COVID-19 en España durante la primera oleada de la pandemia. Aproximación a través del gasto público sanitario por comunidades autónomas Rev Esp Salud Pública., 95 (2021), pp. e1-e10 [Consultado 30 marzo de 2021]. Disponible en: https://www.mscbs.gob.es/biblioPublic/publicaciones/recursos_propios/resp/revista_cdrom/VOL95/O_BREVES/RS95C_202103036.pdf. Google Scholar
  • E. Duysburgh, L. Mortgat, C. Barbezange, K. Dierick, N. Fischer, L. Heyndrickx, et al. Persistence of IgG response to SARS-CoV-2 Lancet Infect Dis., 21 (2021), pp. 163-164, 10.1016/S1473-3099(20)30943-9 ArticleDownload PDFView Record in ScopusGoogle Scholar
  • J. Wang, C. Chen, Q. Li, P. Cai, Z. Wang, L. Wang COVID-19 confirmed patients with negative antibodies results BMC Infect Dis., 20 (2020), p. 698, 10.1186/s12879-020-05419-3 View PDFGoogle Scholar
  • Zunzunegui MV. El exceso de mortalidad por covid-19 en las personas mayores que viven en las residencias de España: variaciones entre comunidades autónomas. Envejecimiento en red. [Consultado 25 marzo de 2021]. Disponible en: https://envejecimientoenred.es/el-exceso-de-mortalidad-por-covid-19-en-las-personas-mayores-que-viven-en-las-residencias-de-espana-variaciones-entre-comunidades-autonomas/. Google Scholar
  • H.B. Mehta, S. Li, J.S. Goodwin Risk Factors Associated With SARS-CoV-2 Infections Hospitalization, and Mortality Among US Nursing Home Residents JAMA Network Open., 4 (2021), p. e216315, 10.1001/jamanetworkopen.2021.6315 View PDFView Record in ScopusGoogle Scholar
Datuen iturria: Dialnet